Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment.

European journal of haematology - 1 Jul 2016

Ansari Junaid, Naqash Abdul Rafeh, Munker Reinhold, El-Osta Hazem, Master Samip, Cotelingam James D, Griffiths Elizabeth, Greer Adam H, Yin Hong, Peddi Prakash, Shackelford Rodney E

Abstract excerpt

Histiocytic sarcoma (HS) is an extremely rare non-Langerhans cell disorder with an aggressive course and limited treatment options. Recent advances in molecular/genetic sequencing have suggested a common clonal origin between various hematolymphoid disorders and cases of secondary HS. Deriving conclusions from previously reported cases of HS arising secondarily to certain hematolymphoid disorders, here we have...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy
Share to Bone Marrow

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cellular Reprogramming

Share to Diagnosis, Differential

Share to Epigenesis, Genetic

Share to In Situ Hybridization, Fluorescence

Share to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Share to Neoplasms, Second Primary

Source

Identifiers

PMID: 26990812
DOI: 10.1111/ejh.12755

Genes

ABL1
BCR
IGH

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment.PMID 26990812Read ↗

Testicular Rosai-Dorfman disease clonally related to CMML – case report and literature reviewSemantic proximity Read ↗

Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy.Semantic proximity Read ↗

KRAS may facilitate transformation of chronic lymphocytic leukemia to histiocytic sarcoma with indeterminate dendritic cell features.Semantic proximity Read ↗

Histiocytic Sarcoma : An Updated Literature Review Based on the 2008 WHO ClassificationSemantic proximity Read ↗

Extranodal Histiocytic Sarcoma: A Clinicopathologic Study of Two Cases and Literature Review.Semantic proximity Read ↗

Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation.Semantic proximity Read ↗

Langerhans cell histiocytosis is a neoplasm and consequently its recurrence is a relapse: In memory of Bob Arceci.Semantic proximity Read ↗

Case report: Targeting the PD-1 receptor and genetic mutations validated in primary histiocytic sarcoma with hemophagocytic lymphohistiocytosis.Semantic proximity Read ↗

B-cell lineage neoplasms transdifferentiating into histiocytic/dendritic cell neoplasms: diversity, differentiation lineage, genomic alterations, and therapy: Report from the 2021 SH/EAHP WorkshopSemantic proximity Read ↗

Molecular characterization of the histiocytoses: Neoplasia of dendritic cells and macrophages.Semantic proximity Read ↗

[Histiocytoses: General classification and molecular criteria].Semantic proximity Read ↗

A Rare Cohesive Cytomorphology in Primary Histiocytic Sarcoma of Bone Marrow with PD-L1 Expression: A case report and systemic literature reviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.